September 29, 2022
PAR-21-037 - Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases (NIAID)
The purpose of this Notice is to alert potential applicants of a change to the Key Dates and Eligibility Information in PAR-21-037, Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed).
Currently Reads:
Part 1. Overview Information
Key Dates
Posted Date
October 20, 2020
Open Date (Earliest Submission Date)
June 28, 2021
Letter of Intent Due Date(s)
30 days prior to the application due date
Application Due Date(s)
July 28, 2021; July 28, 2022; July 28, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
July 28, 2021; July 28, 2022; July 28, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
December 2021; December 2022; December 2023
Advisory Council Review
January 2022; January 2023; January 2024
Earliest Start Date
May 2022; May 2023; May 2024
Expiration Date
July 29, 2023
Due Dates for E.O. 12372
Not Applicable
Section III. Eligibility Information
1. Eligible Applicants
Eligible Organizations
Eligible Organizations:
Non-domestic (non-U.S.) Entities (Foreign Institutions)
Eligible organizations must be in a LMIC, as defined by The World Bank, and include research institutions in LMICs.
Eligible applicant foreign institutions in LMICs are limited to those receiving NIAID grant and/or cooperative agreement funding at the time of application submission.
Eligible organizations must have received no more than $8 million in total NIAID grant and/or cooperative agreement support (primary grantee awards) in the last 5 years at the time of application submission. In order to assure that the US host institutions have appropriate expertise in the management and administration of NIH grants, the applicants' US host institutions are limited to US institutions that, at the time of submission, have received at least $5 million per year in total NIH research grant and/or cooperative agreement support over the last 10 years.
Modified to Read (changes shown in bold italics):
Part 1. Overview Information
Key Dates
Posted Date
October 20, 2020
Open Date (Earliest Submission Date)
June 28, 2021
Letter of Intent Due Date(s)
30 days prior to the application due date
Application Due Date(s)
July 28, 2021; July 28, 2022; December 5, 2022; July 28, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
July 28, 2021; July 28, 2022; December 5, 2022; July 28, 2023
All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
December 2021; December 2022; April 2023; December 2023
Advisory Council Review
January 2022; January 2023; May 2023; January 2024
Earliest Start Date
May 2022; May 2023; July 2023; May 2024
Expiration Date
July 29, 2023
Due Dates for E.O. 12372
Not Applicable
Section III. Eligibility Information
1. Eligible Applicants
Eligible Organizations
Eligible Organizations:
Non-domestic (non-U.S.) Entities (Foreign Institutions)
Eligible organizations must be in a LMIC, as defined by The World Bank, and include research institutions in LMICs.
Eligible applicant foreign institutions in LMICs are limited to those receiving NIAID funding at the time of application submission.
Eligible organizations must have received no more than $8 million in total NIAID grant and/or cooperative agreement support (primary grantee awards) in the last 5 years at the time of application submission. In order to assure that the US host institutions have appropriate expertise in the management and administration of NIH grants, the applicants' US host institutions are limited to US institutions that, at the time of submission, have received at least $5 million per year in total NIH research grant and/or cooperative agreement support over the last 10 years.
All other aspects of the FOA remain unchanged.
LeShawndra N. Price, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Email: [email protected]
and Human Services (HHS)
